Dr. Jack W. Hsu, MD

Dr. Hsu practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Hsu's NPI, 1902867575, was assigned on March 31, 2006. Dr. Hsu graduated from Sidney Kimmel Medical College in 1995. Dr. Hsu holds Florida license ME97921.

Dr. Hsu's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Hsu's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. Dr. Hsu is also affiliated with HCA Florida North Florida Hospital. The medical group on file is North Florida Surgical Associates. Dmand AI also links Dr. Hsu to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hsu practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Hsu's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Hsu is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Hsu's licenses on file in 3 states: Florida, New Jersey and Pennsylvania.

Dmand AI lists chronic anemia, chronic leukemia, lymphoma and multiple myeloma among the conditions Dr. Hsu treats.

CMS data shows 266 Medicare services from Dr. Hsu across 4 procedure codes in 2024, for 98 Medicare patients. Medicare paid $16,413 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 98 Medicare patients who saw Dr. Hsu in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 65% have high cholesterol. 17% are also on Medicaid. Their average risk score is 3.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hsu's median patient age at 67, with 41% women.

In 2024, Dr. Hsu wrote 523 Medicare Part D claims for 66 patients. 79% of them were for generic drugs. CMS names the drug for 317 of them, across 13 drugs with 11 or more claims each, at $1,134,202 in total drug cost. In 2023, CMS named 234 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Hsu for performance year 2024, reported as part of a group. Dr. Hsu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 59 papers to Dr. Hsu, published from 2010 to 2024. 2016 was the busiest year, with 9. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation, Homologous and Graft vs Host Disease. Dr. Hsu has published most often in Biol Blood Marrow Transplant. Dr. Hsu's most frequent co-authors are Maxim Norkin, MD, PhD, John William Hiemenz, MD and Nosha Farhadfar, MD.

Dmand AI links Dr. Hsu to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Leukemia, Megakaryoblastic, Acute, Leukemia, Myeloid, Acute and Multiple Myeloma.

CMS Open Payments shows 18 general payments to Dr. Hsu from 3 drug and device companies from 2016 to 2023. Travel and lodging make up the largest share, 43% of the total. Daiichi Sankyo Inc. paid the most, $4,140. It also lists 1 research payment totaling $5,074 in 2017.

Dr. Hsu graduated from Sidney Kimmel Medical College in 1995.

Dr. Hsu is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.